{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T04:39:41Z","timestamp":1773031181916,"version":"3.50.1"},"reference-count":34,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2011,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            We have compared the efficacy of terbinafine (TRB) and itraconazole (ITZ), the recommended drugs for the treatment of chromoblastomycosis, with that of posaconazole (PSC) and voriconazole (VRC) in athymic mice infected with the fungus\n            <jats:italic>Fonsecaea pedrosoi<\/jats:italic>\n            . Three weeks after challenge, mice were treated for 4 months with PSC at 10 or 20 mg\/kg of body weight\/day, with VRC at 10 or 20 mg\/kg\/day, with ITZ at 25 or 50 mg\/kg\/day, or with TRB at 150 or 250 mg\/kg\/day. The progress of the infection was evaluated by measuring the size of the lesions, by histopathological studies, and by cultures of the excised tissue. The two doses of PSC followed by the highest doses of ITZ and TRB showed the best results while VRC did not show efficacy. PSC could be an alternative in the treatment of chromoblastomycosis.\n          <\/jats:p>","DOI":"10.1128\/aac.01662-10","type":"journal-article","created":{"date-parts":[[2011,5,17]],"date-time":"2011-05-17T04:54:39Z","timestamp":1305608079000},"page":"3709-3713","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":15,"title":["Antifungal Therapy in an Athymic Murine Model of Chromoblastomycosis by\n            <i>Fonsecaea pedrosoi<\/i>"],"prefix":"10.1128","volume":"55","author":[{"given":"Enrique","family":"Calvo","sequence":"first","affiliation":[{"name":"Unitat de Microbiologia, Universitat Rovira i Virgili, Reus, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Javier","family":"Pastor","sequence":"additional","affiliation":[{"name":"Unitat de Microbiologia, Universitat Rovira i Virgili, Reus, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Mayayo","sequence":"additional","affiliation":[{"name":"Unitat d'Anatomia Patol\u00f2gica, Universitat Rovira i Virgili, Reus, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Unitat d'Estad\u00edstica i Epidemiologia, Facultat de Medicina i Ci\u00e8ncies de la Salut, IISPV, Universitat Rovira i Virgili, Reus, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Guarro","sequence":"additional","affiliation":[{"name":"Unitat de Microbiologia, Universitat Rovira i Virgili, Reus, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1989.40.651"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/13693780400011104"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2004.00984.x"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0507.2001.00613.x"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01284-09"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-280X.1999.00189.x"},{"key":"e_1_3_1_8_2","volume-title":"Approved standard M38-A2","author":"Clinical and Laboratory Standards Institute","year":"2008","unstructured":"Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi, 2nd ed. Approved standard M38-A2. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"2"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1990.42.601"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010954803886"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.6.2288-2291.2004"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1080\/mmy.40.5.529.534"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0560.2003.00067.x"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.32.11.1619"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200565110-00007"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00454-06"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.3109\/13693780903471081"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70483-9"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2004.11.020"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkf103"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1080\/13693780802526840"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1080\/13693780802527178"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1086\/380840"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0036-46652005000600006"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2004.07.011"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2000.63.61"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(08)81002-X"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1080\/13693780802538001"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2007.060770"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1080\/mmy.38.3.209.212"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.2.601-604.2001"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.5414\/NPP26021"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704828"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl396"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01445-09"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01662-10","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01662-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T23:18:18Z","timestamp":1645485498000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01662-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["10.1128\/AAC.01662-10"],"URL":"https:\/\/doi.org\/10.1128\/aac.01662-10","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"2010-11-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-05-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-07-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}